Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent auditory hallucinations

Acta Psychiatrica Scandinavica

Volumn 107, Issue 5, 2003, Pages 361-368

  Stant, A D ^a   TenVergert, E M ^a   Groen, H ^a   Jenner, J A ^a,b   Nienhuis, F J ^a   Van De Willige, G ^a   Wiersma, D ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Mental Hlth Care Found Groningen   (Netherlands)

Author keywords

Cost benefit analysis (cost effectiveness); Costs and cost analysis; Hallucinations; Schizophrenia; Therapy

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; AUDITORY HALLUCINATION; BEHAVIOR THERAPY; CARE AS USUAL HEALTH PROGRAM; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HALLUCINATION FOCUSED INTEGRATIVE TREATMENT; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; NETHERLANDS; OUTCOMES RESEARCH; PARANOID SCHIZOPHRENIA; PATIENT COUNSELING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REGISTER; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SENSITIVITY ANALYSIS;

ADULT; COST OF ILLNESS; COST SAVINGS; COST-BENEFIT ANALYSIS; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PATIENT SATISFACTION; PROGRAM EVALUATION; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 0038475790     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2003.00102.x     Document Type: Article

References (37)

1. WIERSMA D, SYTEMA S, VAN BUSSCHBACH J, SCHREURS M, KROON H, DRIESSEN G. Prevalence of long-term mental health care utilization in The Netherlands. Acta Psychiatr Scand 1997;96:247-253.
2. KNAPP M. Schizophrenia costs and treatment cost-effectiveness. Acta Psychiatr Scand 2000;102(suppl. 407): 15-18.
3. HALLAM A, KNAPP M, BEECHAM J et al. Eight years of psychiatric reprovision: an economic evaluation. In: KNAPP M et al., eds. The economic evaluation of mental health care. Aldershot: Arena, 1995:103-124.
4. KAVANAGH SM, STEENBEKKERS JHM. Costs of extramuralisation in mental health care. TNO Prevention and Health, report PG/VGZ/2000.010. Leiden: TNO, 2000.
5. PIJL YJ, KLUITER H, WIERSMA D. Change in Dutch mental health care: an evaluation. Soc Psychiatry Psychiatr Epidemiol 2000;35:402-407.
6. YOUNG JL, ZONANA HV, SHEPLER L. Medication noncompliance in schizophrenia: codification and update. Bull Am Acad Psychiatry Law 1986;14:105-122.
7. MCFARLANE WR, LUKENS E, LINK B et al. Multiple-family groups and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry 1995;52:679-687.
8. DRURY V, BIRCHWOOD M, COCHRANE R, MACMILLAN F. Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. Br J Psychiatry 1996;169:593-601.
9. MOJTABAI R, NICHOLSON RA, CARPENTER BN. Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies. Schizophr Bull 1998;24:569-587.
10. BRENNER HD, HIRSBRUNNER A, HEIMBERG A. Integrated psychological therapy programme: training in cognitive and social skills for schizophrenic patients. In: CORRIGAN PW et al., eds. Cognitive rehabilitation for neuropsychiatric disorders. Washington, DC: APP, 1996.
11. JENNER JA, VAN DE WILLIGE G, WIERSMA D. Effectiveness of cognitive therapy with coping training for persistent auditory hallucinations: a retrospective study of attenders of a psychiatric out-patient department. Acta Psychiatr Scand 1998;98:384-389.
12. JENNER JA, VAN DE WILLIGE G. HIT, hallucination focused integrative treatment as early intervention in psychotic adolescents with auditory hallucinations: a pilot study. Acta Psychiatr Scand 2001;103:148-152.
13. WIERSMA D, JENNER JA, VAN DE WILLIGE G, SPAKMAN M, NIENHUIS FJ. Cognitive behaviour therapy with coping training for persistent auditory hallucinations in schizophrenia: a naturalistic follow-up study of the durability of effects. Acta Psychiatr Scand 2001;103:393-399.
14. KUIPERS E, FOWLER D, GARETY P et al. London-east Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. III: Follow-up and economic evaluation at 18 months. Br J Psychiatry 1998;173:61-68.
15. TARRIER N, LOWSON K, BARROWCLOUGH C. Some aspects of family interventions in schizophrenia. II: Financial considerations. Br J Psychiatry 1991;159:481-484.
16. MCCOMBS JS, NICHOL MB, JOHNSTONE BM, STIMMEL GL, SHI J, SMITH R. Antipsychotic drug use patterns and the cost of treating schizophrenia. Psychiatr Serv 2000;51:525-527.
17. LEWIS M, MCCRONE P, FRANGOU S. Service use and costs of treating schizophrenia with atypical antipsychotics. J Clin Psychiatry 2001;62:749-756.
18. REVICKI DA. Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence. Curr Opin Invest Drugs 2001;2:110-117.
19. GOLD MR, SIEGEL JE, RUSSELL LB, WEINSTEIN MC. Cost-effectiveness in health and medicine. Oxford: Oxford University Press, 1996.
20. GENDUSO LA, HALEY JC. Cost of illness studies for schizophrenia: components, benefits, results, and implications. Am J Manag Care 1997;3:873-877.
21. TARRICONE R, GERZELI S, MONTANELLI R, FRATTURA L, PERCUDANI M, RACAGNI G. Direct and indirect costs of schizophrenia in community psychiatric services in Italy. The GISIES study. Health Policy 2000;51:1-18.
22. MARCOTTE DE, WILCOX-GÖK V. Estimating the employment and earning costs of mental illness: recent developments in the United States. Soc Sci Med 2001;53:21-27.
23. JENNER JA. HIT, an integrative treatment for patients with persistent auditory hallucinations. Psychiatr Serv 2002;53:897-898.
24. HADDOCK G. Auditory hallucination rating scale. Manchester: University of Manchester, 1994.
25. KAY SR, OPLER LA, LINDENMAYER JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 1989;55(Suppl 7):59-67.
26. WIERSMA D, DE JONG A, KRAAIJKAMP HJM, ORMEL J. GSDS-II: the Groningen social disabilities schedule, 2nd ver. Groningen: Rijksuniversiteit Groningen, 1990.
27. DRUMMOND MF, STODDART GL, TORRANCE GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1987.
28. KOOPMANSCHAP MA, RUTTEN FFH, VAN INEVELD BM, VAN ROIJEN L. The friction cost method for measuring indirect costs of disease. J Health Econ 1995;14:171-189.
29. KOOPMANSCHAP MA, VAN INEVELD BM. Towards a new approach for estimating indirect costs of disease. Soc Sci Med 1992;34:1005-1010.
30. OOSTENBRINK JB, KOOPMANSCHAP MA, RUTTEN FFH. Manual for cost studies, methods and standard prices for economic evaluation in health care (In Dutch: Handleiding voor kostenonderzoek, methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg). Amstelveen: Health Care Insurance Council, 2000.
31. EFRON B, TIBSHIRANI RJ. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
32. SIEGEL S, CASTELLAN NJ. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill, 1988.
33. BRIGGS AH, O'BRIEN BJ, BLACKHOUSE G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 2002;23:377-401.
34. MARSHALL M, CROWTHER R, ALMARAZ-SERRANO A et al. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus out-patient care. Health Technol Assess 2001;5:1-75.
35. KNAPP M, CHISHOLM D, LEESE M et al. Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. Acta Psychiatr Scand 2002;105:42-54.
36. GRAY AM, MARSHALL M, LOCKWOOD A, MORRIS J. Problems in conducting economic evaluations alongside clinical trials. Lessons from a study of case management for people with mental disorders. Br J Psychiatry 1997;170:47-52.
37. WHOQoL group. Development of the World Health Organization WHOQoL-BREF Quality of Life Scale. Psychol Med 1998;28:551-558.